The underlying mechanisms involve factors like incretins, somatostatin release, α-cell dysfunction, the loss of the crosstalk between pulsatile insulin and glucagon secretion, etc. The exact mechanisms driving these dysregulations are still under investigation, presenting potential avenues for therapeutic intervention in diabetes management. The gene discussed is INS; the disease is diabetes mellitus.